Izvoz spreman — 

Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial

BACKGROUND: Cumulative evidence from epidemiological, preclinical and clinical studies suggests estrogens may have psychoprotective effects in schizophrenic patients. Selective Estrogen Receptor Modulators could have therapeutic benefits in schizophrenia for both sexes without being hazardous to gyn...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Kianimehr, Gilda, Fatehi, Farzad, Hashempoor, Sara, Khodaei-Ardakani, Mohammad-Reza, Rezaei, Farzin, Nazari, Ali, Kashani, Ladan, Akhondzadeh, Shahin
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2014
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4100751/
https://ncbi.nlm.nih.gov/pubmed/25012765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2008-2231-22-55
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items